Previous 10 | Next 10 |
2024-01-20 06:15:00 ET Summary ClearBridge is a leading global asset manager committed to active management. Research-based stock selection guides our investment approach, with our strategies reflecting the highest-conviction ideas of our portfolio managers. The market’s mi...
2024-01-20 00:49:32 ET Summary In 2015, I started publishing updates regarding my dividend growth portfolio, and I keep doing so every quarter. This is part of being transparent with my readers, so they can see what I hold and its correlation with my writing. This article summ...
2024-01-19 22:20:00 ET Summary ClearBridge is a leading global asset manager committed to active management. Research-based stock selection guides our investment approach, with our strategies reflecting the highest-conviction ideas of our portfolio managers. The ClearBridge Large ...
2024-01-19 04:45:00 ET Summary ClearBridge Large Cap Value Strategy exploits market inefficiencies to identify strong businesses at attractive valuations that can hold for long time periods. U.S. equities made solid gains in the fourth quarter as falling inflation, a dovish pivot ...
2024-01-17 07:12:44 ET Summary Terumo has benefited from improved sentiment in the med-tech sector, as well as its own margin-focused financial outperformance. The company absorbed some revenue headwinds from divestments and weaker glucose monitoring, but core cardiovascular and v...
2024-01-17 04:20:00 ET Summary The beginning of every month is exciting for all dividend income investors as we look back at the previous month and see how much passive dividend income our portfolios generated. Looking back at my December totals, I see that my year-over-year progr...
New Survey by The Harris Poll Highlights Gaps in Cervical Cancer Screening Access PR Newswire Survey Conducted in the US, UK and Sweden Exposes Lack of Education on Options and Unclear Guidance on HPV Testing FRANKLIN LAKES, N.J. , Jan. 10, 2024 /PRNe...
2024-01-09 13:05:55 ET More on Embecta Embecta Corp. (EMBC) Q4 2023 Earnings Call Transcript Embattled Embecta Continues To Present Challenges To Shareholder Value Embecta Non-GAAP EPS of $0.59 beats by $0.19, revenue of $281.9M beats by $10.35M Seeking Alpha...
2024-01-07 17:18:52 ET More on Akoya Biosciences, Exact Sciences, etc. Guardant Health: Vast Market Opportunity, Challenging Valuation Illumina: The Divestiture Of Grail Could Unlock Significant Shareholder Value Illumina: Conditions Are Met For A Rebound Nan...
2024-01-07 10:35:00 ET Summary ClearBridge is a leading global asset manager committed to active management. Research-based stock selection guides our investment approach, with our strategies reflecting the highest-conviction ideas of our portfolio managers. The market’s mi...
News, Short Squeeze, Breakout and More Instantly...
Becton Dickinson and Company Company Name:
BDX Stock Symbol:
NYSE Market:
Becton Dickinson and Company Website:
2024-07-11 12:00:00 ET July 11, 2024 (Investorideas.com Newswire) Investorideas.com , a go-to investing platform releases the second of a two-part series looking at recent news and developments in the blood infections treatment market, featuring Citius Pharmaceuticals, Inc. ( Nasdaq:C...
BD Statement on Supplier Issue Impacting BD BACTEC™ Blood Culture Vials PR Newswire Company Committed to Support Global Health and Customers BD Taking all Available Measures to Mitigate Supplier Issue FRANKLIN LAKES, N.J. , July 10 , 2024...
BD Surpasses Scope 1 and 2 Reduction Milestones for FY 2023 PR Newswire FRANKLIN LAKES, N.J. , July 10 , 2024 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has surpassed its Scope 1...